BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.43 -0.05 (2.02%)
Previous Close $2.48    52 Week High $1.63 
Open $2.48    52 Week Low $0.71 
Day High $2.60    P/E N/A 
Day Low $2.42    EPS $0.00 
Volume 10,354       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.43 -0.05 (2.02%)
Previous Close $2.48    52 Week High $1.63 
Open $2.48    52 Week Low $0.71 
Day High $2.60    P/E N/A 
Day Low $2.42    EPS $0.00 
Volume 10,354